Galantamine: a randomized, double-blind,
β
D. Wilkinson; J. Murray
π
Article
π
2001
π
John Wiley and Sons
π
English
β 87 KB
π 2 views
## Abstract ## Objectives To investigate whether Galantamine significantly improves the core symptoms of Alzheimer's disease (AD). ## Background Galantamine is a reversible, competitive, selective inhibitor of acetylcholinesterase (AChE) that also allosterically modulates nicotinic acetylcholine